Replies to post #244557 on Biotech Values

[DewDiligence]

ISEE NDA has 8/19/23 PDUFA date—(with FDA priority review):

https://www.businesswire.com/news/home/20230216005773/en

ISEE’s avacincaptad pego for geographic atrophy had FTA BTD, so a priority review was a fait accompli.